Specific enzyme-linked immunosorbent assays for quantitation of antibody-cytokine fusion proteins

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 2, 1999, Pages 236-242

  Gan, J ^a   Kendra, K ^a   Ricci, M ^a   Hank, J A ^a   Gillies, S D ^b   Sondel, P M ^a,c,d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Lexigen Pharmaceuticals Corp   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2; MONOCLONAL ANTIBODY;

ANALYTIC METHOD; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPRODUCIBILITY;

EID: 0033044984     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.2.236-242.1999     Document Type: Article

References (27)

1. Baker, D., D. Butler, B. J. Scallon, J. K. O'Neill, J. L. Turk, and M. Feldmann. 1994. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24:2040-2048.
2. Bogers, W. M., F. Lang, K. E. Parker, B. LeMauff, I. Anegon, Y. Jacques, and J. P. Soulillou. 1994. Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivo. Transplantation 58:932-939.
3. Gillies, S. D., E. B. Reilly, K. M. Lo, and R. A. Reisfeld. 1992. Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells. Proc. Natl. Acad. Sci. USA 89:1428-1432.
4. Gillies, S. D., D. Young, K. Lo, and S. Roberts. 1993. Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins. Bioconjug. Chem. 4:230-235.
5. Hand, P. H., S. V. S. Kashmiri, and J. Schlom. 1994. Potential for recombinant immunoglobulin constructs in the management of carcinoma. Cancer 73(Suppl.):1005-1113.
6. a. Handgretinger, R. (Tübingen, Germany). Personal communication.
7. Hu, P., J. L. Hornick, M. S. Glasky, A. Yun, M. N. Milkie, L. A. Khawli, P. M. Anderson, and A. L. Epstein. 1996. A chimeric Lym-1/interleukin 2 fusion protein for increasing tumor vascular permeability and enhancing antibody uptake. Cancer Res. 56:4998-5004.
8. Ida, N., S. Sakurai, K. Hosoi, and T. Kunitomo. 1992. A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids. J. Immunol. Methods 156:27-38.
9. Jabara, H. H., D. Vercelli, L. C. Schneider, D. P. Williams, F. S. Genbauffe, L. R. Poisson, C. A. Waters, and R. S. Geha. 1995. Interleukin-4 receptor expression by human B cells: functional analysis with a human interleukin-4 toxin, DAB389IL-4. J. Allergy Clin. Immunol. 95:893-900.
10. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
11. Lode, H. N., R. Xiang, N. M. Varki, C. S. Dolman, S. D. Gillies, and R. A. Reisfeld. 1997. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow. J. Natl. Cancer Inst. 89:1586-1594.
12. Milenic, D. E., T. Yokota, D. R. Filpula, M. A. J. Finkelman, S. W. Dodd, J. F. Wood, M. Whitlow, P. Snoy, and J. Schlom. 1991. Construction, binding properties, metabolism and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res. 51:6363-6371.
13. Morrison, S. L., L. A. Wims, and V. T. Oi. 1988. Genetically engineered antibody molecules: new tools for cancer therapy. Cancer Investig. 6:185-192.
14. Naramura, M., S. D. Gillies, J. Mendelsohn, R. A. Reisfeld, and B. M. Mueller. 1994. Mechanisms of cellular cytotoxicity mediated hy a recombinant antibody-IL2 fusion protein against human melanoma cells. Immunol. Lett. 39:91-99.
15. Nicolet, C. M., J. K. Burkholder, J. Gan, J. Culp, S. V. S. Kashmiri, J. Schlom, N.-S. Yang, and P. M. Sondel. 1995. Expression of a tumor-reactive antibody-interleukin 2 fusion protein after in vivo particle-mediated gene delivery. Cancer Gene Ther. 2:161-170.
16. Pancook, J. D., J. C. Becker, S. D. Gillies, and R. A. Reisfeld. 1996. Eradication of established hepatic human neuroblastoma meastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2. Cancer Immunol. Immunother. 42:88-92.
17. Reisfeld, R. A., and S. D. Gillies. 1996. Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy. J. Clin. Lab. Anal. 10:160-166.
18. Sabzevari, H., S. D. Gillies, B. M. Mueller, J. D. Pancook, and R. A. Reisfeld. 1994. A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice. Proc. Natl. Acad. Sci. USA 91:9626-9630.
19. Saleh, M. N., M. B. Khazaeli, R. H. Wheeler, R. P. Bucy, T. Liu, M. P. Everson, D. H. Munn, J. Schlom, and A. F. LoBuglio. 1995. Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer. Cancer Res. 55:4339-4346.
20. Savage, P., A. So, R. A. Spooner, and A. A. Epentos. 1993. A recombinant single chain antibody interleukin-2 fusion protein. Br. J. Cancer 67:304-310.
21. Sen, G., M. Chakraborty, K. A. Foon, R. A. Reisfeld, and M. Bhattacharya-Chatterjee. 1997. Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2. Clin. Cancer Res. 3:1969-1976.
22. Shin, S. U., and S. L. Morrison. 1989. Production and properties of chimeric antibody molecules. Methods Enzymol. 178:459-478.
23. Shu, L., C.-F. Qi, J. Schlom, and S. V. S. Kashmiri. 1993. Secretion of a single-gene-encoded immunoglobulin from myeloma cells. Proc. Natl. Acad. Sci. USA 90:7995-7999.
24. Slavin-Chiorini, D. C., P. H. Horan Hand, S. V. S. Kashmiri, B. Calvo, S. Zaremba, and J. Schlom. 1993. Biologic properties of CH2 domain-deleted recombinant immunoglobulins. Int. J. Cancer 53:97-103.
25. Thavasu, P. W., S. Longhurst, S. P. Joel, M. L. Slevin, and F. R. Balkwill. 1992. Measuring cytokine levels in blood: importance of anticoagulants, processing, and storage conditions. J. Immunol. Methods 153:115-134.
26. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
27. Xiang, R., H. N. Lode, C. S. Dolman, T. Dreier, N. M. Varki, X. Qian, K.-M. Lo, Y. Lan, M. Super, S. D. Gillies, and R. A. Reisfeld. 1997. Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy. Cancer Res. 57:4948-4955.